ATXI - Avenue Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 599.36M
Enterprise Value 380.59M
Trailing P/E N/A
Forward P/E 1-6.45
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)7.14
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) -0.41
52-Week Change 356.33%
S&P500 52-Week Change 30.90%
52 Week High 37.98
52 Week Low 32.08
50-Day Moving Average 36.00
200-Day Moving Average 35.49

Share Statistics

Avg Vol (3 month) 360.36k
Avg Vol (10 day) 315.53k
Shares Outstanding 516.56M
Float 5.42M
% Held by Insiders 161.73%
% Held by Institutions 14.54%
Shares Short (Jul 31, 2019) 421.03k
Short Ratio (Jul 31, 2019) 41.22
Short % of Float (Jul 31, 2019) 40.31%
Short % of Shares Outstanding (Jul 31, 2019) 40.13%
Shares Short (prior month Jun 28, 2019) 444.12k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-125.32%
Return on Equity (ttm)-261.77%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-24.77M
Diluted EPS (ttm)-1.96
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)15.46M
Total Cash Per Share (mrq)0.93
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.84
Book Value Per Share (mrq)0.84

Cash Flow Statement

Operating Cash Flow (ttm)-24.92M
Levered Free Cash Flow (ttm)-15.96M